What antibiotics are used to treat skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics for Skin Infections

For uncomplicated skin and soft tissue infections, first-line oral antibiotics include cephalexin (500 mg four times daily), dicloxacillin (500 mg four times daily), or clindamycin (300-450 mg three times daily), with selection based on suspected pathogens and local MRSA prevalence. 1

Impetigo and Superficial Infections

  • Oral therapy for 7 days with dicloxacillin 250 mg four times daily or cephalexin 250 mg four times daily is recommended for impetigo when systemic treatment is needed 2, 1
  • Topical mupirocin ointment applied three times daily is an alternative for localized disease 1
  • When MRSA is suspected or confirmed, use doxycycline, clindamycin, or trimethoprim-sulfamethoxazole 2
  • If cultures yield streptococci alone, oral penicillin is the preferred agent 2

Cellulitis and Erysipelas

Mild Cellulitis (No Systemic Signs)

  • Target streptococci with cephalexin 500 mg every 6 hours or dicloxacillin 2
  • Treat for 5 days minimum, extending if not improved 2

Moderate Cellulitis (With Fever or Systemic Signs)

  • Many clinicians include MSSA coverage with cephalexin or dicloxacillin 2
  • Consider MRSA coverage if penetrating trauma, purulent drainage, known MRSA colonization, injection drug use, or systemic inflammatory response syndrome (SIRS) present 2

Severe Cellulitis (MRSA Risk Factors or SIRS)

  • Vancomycin 15 mg/kg every 12 hours IV or another agent effective against both MRSA and streptococci 2
  • For severely immunocompromised patients, use broad-spectrum coverage: vancomycin plus piperacillin-tazobactam or a carbapenem 2

Abscesses and Furuncles

  • Incision and drainage is the primary treatment; systemic antibiotics usually unnecessary unless fever or systemic infection present 2
  • If antibiotics indicated, obtain cultures and treat with a 5-10 day course active against the isolated pathogen 2
  • For MRSA abscesses requiring antibiotics: trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily, doxycycline 100 mg twice daily, or clindamycin 1

Bite Wounds (Animal or Human)

  • Amoxicillin-clavulanate 875/125 mg twice daily orally is the recommended first-line agent 1
  • IV option: ampicillin-sulbactam 1.5-3.0 g every 6-8 hours 1
  • These provide coverage for both aerobic and anaerobic bacteria 2

Necrotizing Infections

  • Urgent surgical debridement is mandatory 2
  • Empiric broad-spectrum therapy: vancomycin plus piperacillin-tazobactam, ampicillin-sulbactam, or a carbapenem 2
  • For documented group A streptococcal necrotizing fasciitis: penicillin 2-4 million units every 4-6 hours IV plus clindamycin 600-900 mg every 8 hours IV 2

MRSA-Specific Oral Options

  • Linezolid 600 mg twice daily 1
  • Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily 1
  • Doxycycline 100 mg twice daily (avoid in children under 8 years) 1
  • Clindamycin 300-450 mg three times daily 1

MSSA-Specific Options

  • Nafcillin or oxacillin 1-2 g every 4 hours IV 1
  • Dicloxacillin 500 mg four times daily orally 1
  • Cefazolin 1 g every 8 hours IV 2

Pediatric Dosing

  • Cephalexin: 25-50 mg/kg/day in divided doses 3
  • For streptococcal pharyngitis and skin infections, may divide total daily dose every 12 hours 3
  • For otitis media, 75-100 mg/kg/day in 4 divided doses required 3
  • For β-hemolytic streptococcal infections, treat for at least 10 days to prevent rheumatic fever 1, 3

Critical Pitfalls to Avoid

  • Do not rely on antibiotics alone for abscesses—drainage is essential 2
  • Examine interdigital toe spaces in lower extremity cellulitis; treating tinea pedis reduces recurrence 2
  • Obtain cultures for recurrent infections, treatment failures, or severe infections 1
  • Local resistance patterns should guide empiric therapy—MRSA prevalence varies significantly by region 1
  • Avoid cephalosporins as monotherapy when MRSA is suspected or confirmed 2

References

Guideline

Antibiotic Treatment for Skin and Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.